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A B S T R A C T
Spray drying is a valuable technique in pharmaceutical dosage formulation, capable of producing
amorphous, spherical powders, suitable for pulmonary deposition and further downstream processing.
In this study, we show that spray drying bacteriophages together with trehalose results in an amorphous
powder matrix with high glass transition temperature (between 116 and 118 C), typical for amorphous
trehalose. These powders are stable at low temperatures (4 C) and relative humidity (0%). However, high
humidity causes crystallization of the amorphous matrix, destroying the embedded phages.
Furthermore, storage at higher temperature (25 C) causes thermal instability of the embedded phages.
The results show that storage conditions are important parameters to take into account in phage therapy
development. The resulting particles are hollow spheres, with suitable aerodynamic diameters for
deposition into the deep lungs. This opens possibilities to use these phage-containing powder
formulations to tackle pulmonary infectious diseases, especially caused by antibiotic resistant pathogens.
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(Bacterio)phage therapy recently gained scientific and medical
attention. As most studies focus on liquid bacteriophage for-
mulations, little is known about the possibilities of processing
bacteriophages into different pharmaceutical formulations, with
the few studies mainly using lyophilization to process liquid
formulations into dry powders (Merabishvili et al., 2013). Recently,
the potential of spray drying bacteriophages into readily usable
powder formulations for aerosolation was shown (Matinkhoo
et al., 2011; Vandenheuvel et al., 2013). Trehalose was added
because of its known capacity to protect biomaterials from
desiccation and thermal stress (Crowe et al., 1998; Grasmeijer
et al., 2013). This ability of thermal and dehydration protection is
explained via the water-replacement hypothesis and the vitrifica-
tion hypothesis. In these hypotheses, trehalose provides structural
and conformational stability to the proteins by direct hydrogen
bond formation or vitrifying the protein, hence limiting the
protein’s mobility. The glassy state of trehalose shows a high glass
transition temperature (Tg), between 79 and 115 C (Willart et al.,
2002), which promises a stable glassy matrix at room temper-
atures. This research focuses on the importance of storage
conditions and the stability of the powder matrix as well as the* Corresponding author. Tel.: +32 16 330 304.
E-mail address: guy.vandenmooter@pharm.kuleuven.be (G. Van den Mooter).
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0378-5173/ã 2014 Elsevier B.V. All rights reserved.negative effects of crystal formation on the viability of phages in
spray-dried powders. These effects are important considerations in
the development of phage-containing pharmaceuticals and the
optimization of their mode of storage and packaging.
The powders in this study were manufactured as described
previously (Vandenheuvel et al., 2013). In short, a 4% (w/v)
trehalose solution (Acros Organics, Belgium), supplied with 1%
(v/v) phage suspension of Pseudomonas aeruginosa phage LUZ19 or
Staphylococcus aureus phage Romulus was spray dried using a
Micro Spray laboratory-scale spray dryer (ProCepT, Belgium) with
following process parameters: atomization was done using a bi-
fluid nozzle with an orifice of 0.6 mm and atomizing airflow of
6 l/min, the liquid feed was supplied at 2 ml/min and dried in the
drying chamber (300 l/min heated air of 85 C). After spray drying,
the powders were immediately stored at a temperature and
humidity controlled atmosphere. Storage temperature was 4 or
25 C. Using saturated salt solutions of phosphorus pentoxide and
magnesium nitrate the relative humidity (RH) was adapted to 0
and 54%, respectively. The use of powders in respirable applica-
tions and metered dose inhalers (MDIs) is highly dependent on the
particle size. Particles with an aerodynamic diameter ranging from
1 to 5 mm settle down in the deep lungs. We previously showed
that particle size and size distribution was phage dependent, with
phage Romulus resulting in a larger fine particle fraction compared
to phage LUZ19 (Vandenheuvel et al., 2013). These results were
confirmed with field emission gun scanning electron microscopy
(FEG-SEM), performed with a Philips XL30 ESEM-FEG microscope
Fig. 1. SEM images of bacteriophage-containing trehalose powders. (A) LUZ19-containing powder particles. (B) Romulus-containing powder particles. (C) Close-up on a
Romulus-containing particle, showing the hollow inside.
Fig. 2. Stability of bacteriophage titer. (A) Loss of viable LUZ19 phages during one
year of storage in controlled conditions. (B) Loss of viable Romulus phages during
one year of storage in controlled conditions (n = 3). Standard deviations were
calculated but not shown to improve the readability of the graphics. For data points
marked with an asterisk (*), n = 2 due to detection limitations.
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aluminum stubs using double-sided carbon tape and gold coated
by gold sputtering for 45 s at 20 mA and images were taken at a
10 kV electron acceleration voltage. Fig. 1 shows microscopic
images of the powder samples, confirming that the powder
particles were hollow spheres with relative smooth to golf ball-like
surfaces. Although SEM cannot provide absolute numbers, the
images clearly show that the powder sample containing LUZ19
results in more large particles compared to the Romulus-
containing powder, supporting the previous light microscopic
data. The average density of spray-dried non phage-containing and
phage-containing trehalose particles was measured via helium
pycnometry and found to be 1.47 g/cm3. For spherical particles, the
geometric and aerodynamic diameter are related as
follows: da ¼ dg
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
r=r0x
p
; with da the aerodynamic diameter, dg
the geometric diameter, r and r0 the particle and unit density,
respectively, and x the shape factor which is 1 for spherical
particles (Pilcer and Amighi, 2010). This results in suitable
geometric diameters for deep pulmonary deposition ranging from
0.82 to 4.12 mm. The powders are confirmed to have a suitable fine
particle fraction, with spherical, hollow particles which favors
pulmonary delivery through aerosolation.
To study the viability of powder-embedded phages during long-
term storage, the surviving infectious phages were titrated
immediately after powder production and subsequently on a
monthly basis for one year. Titers were determined by plating a
proper dilution of a dissolved powder sample in presence of a host
bacterium using the standard double agar overlay method as
described earlier (Vandenheuvel et al., 2013) (Fig. 2). Freshly spray-
dried powder samples were divided in four groups and stored at
Fig. 3. MDSC curves. (A) Trehalose dihydrate. (B) Spray-dried amorphous trehalose. (C) Romulus-containing spray-dried trehalose. (D) LUZ19-containing spray-dried
trehalose. Arrows mark the Tg.
Fig. 4. X-ray diffraction profiles of stored samples. X-ray diffraction patterns of unprocessed trehalose dihydrate and samples stored at different atmospheres.
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25 C and 0% RH, and 25 C and 54% RH. Each powder sample was
made and analyzed in triplicate. Both phages were the most stable
at 4 C and 0% RH. LUZ19 showed no significant loss of phage titer.
However, the logarithmic loss of phage titer for Romulus at these
conditions was about 2 log units over the course of one year, but
seemed to stabilize after the initial loss. Remarkably, after one year
of storage the most damaging conditions were found to be 25 C
and 0% RH.
To investigate the relationship between this loss of viable
phages and crystallization of the amorphous trehalose, the powder
matrix was studied by powder X-ray diffraction (PXRD) and
modulated differential scanning calorimetry (MDSC). To confirm
the amorphous character of the spray-dried trehalose powders,
PXRD was used to analyze spray-dried trehalose powders. New
powder samples were produced and kept at 4 C and 0% RH until
measurement, and analyzed in reflection mode using zero
background sample holders, with an X’pert PRO diffractometer
(PANalytical, The Netherlands), equipped with a Cu X-ray source
(lKa = 1.5405 Å) from 4 to 40 2u. Data acquisition and analysis were
done using the X’pert Data Collector and the X’pert Data Viewer,
respectively. The resulting diffractograms were compared to a
diffractogram of unprocessed trehalose dihydrate. The absence of
characteristic trehalose dihydrate crystal peaks (8.8 and 23.9)
and the presence of an amorphous halo showed that the powder
samples were X-ray amorphous after spray drying (data not
shown). Furthermore, the Tg was determined using MDSC (Fig. 3),
performed on a DSC Q2000 (TA Instruments, UK). Therefore,
samples with a mass between 3.00 and 4.50 mg were placed in
sealed aluminum pans and scanned from 70 to 150 C, with a
heating rate of 2 C/min and a nitrogen purge of 50.0 ml/min. The
modulation period was 40 s, with a 0.64 C amplitude. The
obtained data were analyzed using the Universal Analysis 2000
software (version 4.5A) (TA Instruments). Temperature calibration
was done using indium and octadecane. Enthalpic and heat
capacity calibration were done using indium and sapphire,
respectively. Melting enthalpies and Tgs were studied using heat
flow curves and reversing heat flow curves, respectively. Being
fully crystalline, trehalose dihydrate did not show a glass
transition. Instead, the heat flow curve showed an endothermic
peak (93.1 C), representing the melting of the crystals. Spray-dried
trehalose without phages showed a glass transition temperature of
118.7 C, for Romulus and LUZ19-containing powders this was
116.4 C and 117.2 C, respectively. The presence of a Tg and the
absence of the endothermic peak, indicate the fullyamorphousstate
of the powders. Powder samples which were stored for at least eight
months at controlled atmosphere showed different heat flow
profiles (data not shown). Samples stored at the highest humidity
agglomerated, regardless of the storage temperature. The samples
did not show a Tg, but an endothermic peak with set off temperature
between 86 and 91 C appeared. This peak concurs with the melting
transition of pure non-processed trehalose dihydrate. The X-ray
diffractograms of these samples showed Bragg peaks typical for
crystalline trehalose dihydrate (Fig. 4). This indicates that at 54% RH
amorphous trehalose is able to form stable trehalose dihydrate
crystals, regardless of the storage temperature. This leads to the
conclusion that loss of the amorphous structure and the formation
of crystals is causing the high drop in phage titer observed in these
samples. Samples that were stored at a dryatmospheredid notshow
any change in DSC or PXRD patterns. The amorphous trehalose
powdermatrix was stable and no crystallization took place, possibly
explained by the absence of water in the atmosphere.
Two Romulus-containing samples showed an unexpected high
drop in viable phage titer (data not shown). These samples were
stored at 0% RH and different temperatures. The heat flow curves
revealed the presence of crystalline trehalose, which was alsoconfirmed by X-ray diffraction analysis (data not shown). Since
other samples stored at the same atmospheric conditions were
amorphous, these samples were possibly subjected to an instable
atmosphere during storage (e.g., desiccator was not tightly sealed,
drying capacity of the salt was exceeded) and crystallization
occurred. Although it was impossible to link the exact moment of
crystallization with the time of phage titer drop, these results
indicate the importance of the amorphous glassy matrix and its
protective effect on the embedded biologicals.
In conclusion, we demonstrate that spray-dried phage-con-
taining trehalose particles require specific storage conditions
which limit crystal formation. A storage temperature below the Tg
of trehalose was insufficient to prevent crystallization and protect
the embedded phages. Crystallization could occur at temperatures
far below the glass transition temperature of the spray-dried
amorphous trehalose powders when the relative humidity was
high. Thus, to prevent crystallization, controlling the relative
humidity seems to be the more important factor over temperature.
This transformation of amorphous trehalose to crystalline treha-
lose dihydrate in high humidity atmospheres is consistent with
previous studies (Iglesias et al., 1997; Nagase et al., 2002; Surana
et al., 2004). Furthermore, storage temperature had a pronounced
effect on phage viability. Over time, the phage titer declined at
25 C even when no crystallization of the amorphous trehalose
matrix was observed, but stayed more stable at 4 C. As expected,
the effects of crystal formation on phage viability appears phage
specific. Larger phage virions are more prone to inactivation upon
crystal formation than smaller phage virions. Although the
observations above show that storage of spray-dried phage-
containing trehalose powders is not straightforward, one should be
mindful of the possibilities for further downstream processing,
handling and aerosolizing these powders. The potential of these
dry powders in aerosol therapy to tackle pulmonary bacterial
infection diseases is only one example of the possibilities yet to be
studied.
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